RE:Anyone surprised with the sp direction?? Balance sheet is I guess it is going to be that way until the official FDA response for Pg BLA.
I believe the market does not fully make the difference for Plasminogene BLA versus any other chemical coumpound's BLA..
Since the rate of approval is quite low for chemical coumpound (only 4% of IND reaches a BLA), if the market does not fully understand the difference between a human protein and a chemical drug, then there are probably a lot of nervous investor waiting for a positive response.
and since the official FDA response time is already past, many investor are probably nervous and the traders and shorters benefit from this lack of confidence
IMHO again